Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2022-07-07 Director's Dealing
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Powiadomienie
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). This regulation (Market Abuse Regulation) mandates reporting of transactions conducted by Persons Discharging Managerial Responsibilities (PDMRs). The content explicitly details a transaction ('Nabycie' - Acquisition) involving shares by an individual ('Mariusz Nowak') holding a management position ('Przewodniczący Rady Nadzorczej' - Chairman of the Supervisory Board) in the issuer ('BioMaxima Spółka Akcyjna'). This perfectly matches the definition of Director's Dealing (insider trades by executives/directors).
2022-07-07 Polish
Zawiadomienie od osoby zobowiązanej - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is extremely short (132 characters) and states in Polish that the Management Board of BioMaxima SA received a notification from Mr. Mariusz Nowak, which constitutes an attachment to the current report ("które stanowi załacznik do niniejszego raportu"). This structure strongly suggests an announcement about receiving or attaching a document, rather than the document itself. Since the content is a notification regarding an individual's action (likely a director or major shareholder transaction, given the context of corporate filings), and it is presented as a brief regulatory filing announcement, the most appropriate classification is Regulatory Filing (RNS) as a general announcement fallback, or potentially DIRS if the attachment was a Director's Dealing form, but RNS is safer for a generic notification announcement.
2022-07-07 Polish
Zestawienie transakcji
Transaction in Own Shares Classification · 95% confidence The document text consists almost entirely of tabular data showing transaction records, including codes (KOD_PW), quantities (IL_ZREA), prices (KURS), total values (WARTOSC), and dates (DATA_NOTY, DATA_ROZL). The presence of 'PLBIOMX00015' suggests a specific security or exchange context, and the data structure strongly resembles trade confirmations or transaction reports. This type of raw, structured data, especially when presented in a non-narrative format, is most closely aligned with supplementary data that might be provided in an Excel format, or a very specific regulatory filing detailing transactions. Given the options, and the highly structured, non-narrative nature of the content which looks like raw trade data dumps, it is best classified as Financial Supplement Data (XLSX), assuming this table represents the content of a data file rather than a narrative report. If this were a regulatory filing about insider trading, it would be DIRS, but the format here is purely transactional data, not a director's declaration.
2022-07-07 English
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text, written in Polish, details the acquisition of the company's own shares ('akcji własnych') by the Issuer ('Emitent') over several trading days (June 30 to July 6, 2022). It specifies the number of shares bought, the average price, and the resulting percentage of share capital and voting rights. This activity directly corresponds to a share repurchase program. The legal basis cited (Commission Delegated Regulation (EU) 2016/1052) also pertains to share buyback programs. Therefore, the correct classification is Transaction in Own Shares (POS). The document is a report of the transaction, not just an announcement of a report.
2022-07-07 Polish
Informacja o programie skupu akcji własnych - Content (PL)
Transaction in Own Shares Classification · 100% confidence The document text explicitly discusses the commencement of a share buyback program ('program skupu akcji własnych') authorized by a General Meeting resolution. It details the purpose (reducing capital), the maximum amount (5,000,000 PLN), the maximum price per share (33 PLN), the maximum number of shares (432,000), the timeline (until October 31, 2022), and the methods of acquisition (session and block trades). This content directly relates to the company repurchasing or selling its own shares, which corresponds to the definition of 'Transaction in Own Shares' (POS). It is not an earnings release (ER), an interim report (IR), or a general capital change (CAP), but a specific action regarding treasury stock.
2022-06-29 Polish
Stan realizacji umowy na dostawy analizatorów - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is very short (around 500 characters) and appears to be a brief operational update from the Management Board (Zarząd) of BioMaxima S.A. It announces the delivery of a product (cell culture analyzer) and mentions future revenue streams from consumables. This type of specific, non-standard operational announcement, which doesn't fit neatly into defined financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, MANG), is best classified under the general regulatory announcement category.
2022-06-21 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.